MLICM
REPL icon

Metropolitan Life Insurance Company (MetLife)’s Replimune Group REPL Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,616
Closed -$21.4K – 1660
2024
Q1 		$21.4K Hold
2,616
– – ﹤0.01% 1822
2023
Q4 		$22.1K Hold
2,616
– – ﹤0.01% 1879
2023
Q3 		$44.8K Buy
2,616
+387
+17% +$7.6K ﹤0.01% 1468
2023
Q2 		$51.8K Sell
2,229
-299
-12% -$5.84K ﹤0.01% 1394
2023
Q1 		$44.6K Buy
2,528
+76
+3% +$1.81K ﹤0.01% 1448
2022
Q4 		$66.7K Hold
2,452
– – ﹤0.01% 1303
2022
Q3 		$42.3K Buy
2,452
+714
+41% +$13.6K ﹤0.01% 1573
2022
Q2 		$30.4K Hold
1,738
– – ﹤0.01% 1810
2022
Q1 		$29.5K Sell
1,738
-5,344
-75% -$101K ﹤0.01% 1895
2021
Q4 		$192K Hold
7,082
– – ﹤0.01% 2054
2021
Q3 		$210K Hold
7,082
– – ﹤0.01% 2028
2021
Q2 		$272K Buy
7,082
+357
+5% +$12.2K ﹤0.01% 1936
2021
Q1 		$205K Hold
6,725
– – ﹤0.01% 2005
2020
Q4 		$257K Hold
6,725
– – ﹤0.01% 1774
2020
Q3 		$155K Buy
6,725
+366
+6% +$8.34K ﹤0.01% 1940
2020
Q2 		$158K Buy
+6,359
New +$112K ﹤0.01% 1967

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s REPL Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Replimune Group (REPL) in Q2 2024, closing a stake of 2,616 shares — an estimated $21.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in REPL in Q2 2020 and held it in 16 quarters. The position peaked at $272K in Q2 2021. 149 funds tracked by Wall St. Rank hold REPL as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Replimune Group position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,616 Replimune Group shares in Q2 2024, an estimated $21.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Replimune Group in Q2 2020 and held it in 16 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Replimune Group position peaked at $272K in Q2 2021.
  • 149 funds tracked by Wall St. Rank held Replimune Group as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.